apomorphine
SMILES | CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O |
InChIKey | VMWNQDUVQKEIOC-CYBMUJFWSA-N |
Chemical properties
Hydrogen bond acceptors | 3 |
Hydrogen bond donors | 2 |
Rotatable bonds | 0 |
Molecular weight (Da) | 267.1 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 6.9 | 6.9 | 6.9 | Guide to Pharmacology |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.9 | 6.9 | 6.9 | Guide to Pharmacology |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.9 | 6.9 | 6.9 | Guide to Pharmacology |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 7.0 | 7.0 | 7.0 | Guide to Pharmacology |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 6.9 | 6.9 | 6.9 | Guide to Pharmacology |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.2 | 7.2 | 7.2 | Guide to Pharmacology |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 7.4 | 7.4 | 7.4 | Guide to Pharmacology |
D1 | DRD1 | Human | Dopamine | A | pKi | 5.3 | 5.75 | 6.2 | Guide to Pharmacology |
D2 | DRD2 | Human | Dopamine | A | pKi | 5.7 | 6.6 | 7.5 | Guide to Pharmacology |
D3 | DRD3 | Human | Dopamine | A | pKi | 6.1 | 6.85 | 7.6 | Guide to Pharmacology |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.4 | 8.4 | 8.4 | Guide to Pharmacology |
D5 | DRD5 | Human | Dopamine | A | pKi | 6.4 | 7.1 | 7.8 | Guide to Pharmacology |
5-HT7 | 5HT7R | Rat | 5-Hydroxytryptamine | A | pKi | 6.73 | 6.73 | 6.73 | ChEMBL |
D1 | DRD1 | Rat | Dopamine | A | pKi | 6.0 | 6.59 | 7.28 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pKi | 7.01 | 7.86 | 8.74 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pKd | 5.8 | 6.16 | 6.7 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.05 | 8.05 | 8.05 | ChEMBL |
5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pKi | 6.53 | 6.53 | 6.53 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKd | 6.17 | 6.17 | 6.17 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 6.18 | 6.78 | 8.34 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pKi | 7.77 | 8.12 | 8.59 | ChEMBL |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 6.27 | 6.56 | 6.93 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 6.61 | 7.48 | 9.21 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKd | 6.9 | 7.9 | 9.18 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.13 | 8.13 | 8.13 | Drug Central |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
5-HT1B | 5HT1B | Human | 5-Hydroxytryptamine | A | pKi | 8.26 | 8.26 | 8.26 | Drug Central |
5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 8.23 | 8.23 | 8.23 | Drug Central |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 8.15 | 8.15 | 8.15 | Drug Central |
α1A | ADA1A | Human | Adrenoceptors | A | pKi | 8.24 | 8.24 | 8.24 | Drug Central |
α1B | ADA1B | Human | Adrenoceptors | A | pKi | 8.21 | 8.21 | 8.21 | Drug Central |
α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.04 | 8.04 | 8.04 | Drug Central |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.09 | 8.09 | 8.09 | Drug Central |
D5 | DRD5 | Human | Dopamine | A | pKi | 8.11 | 8.11 | 8.11 | Drug Central |
5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
D2 | DRD2 | Bovine | Dopamine | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
D1 | DRD1 | Rat | Dopamine | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
5-HT7 | 5HT7R | Rat | 5-Hydroxytryptamine | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
D2 | DRD2 | Rat | Dopamine | A | pKi | 8.06 | 8.06 | 8.06 | Drug Central |
D1 | DRD1 | Mouse | Dopamine | A | pKi | 8.15 | 8.15 | 8.15 | Drug Central |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.92 | 6.92 | 6.92 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 8.08 | 8.08 | 8.08 | Drug Central |
D5 | DRD5 | Human | Dopamine | A | pKi | 7.82 | 7.82 | 7.82 | ChEMBL |
D2 | DRD2 | Bovine | Dopamine | A | pKi | 6.7 | 6.7 | 6.7 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pKi | 7.6 | 7.6 | 7.6 | Guide to Pharmacology |
D1 | DRD1 | Mouse | Dopamine | A | pKi | 7.0 | 7.0 | 7.0 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
D1 | DRD1 | Rat | Dopamine | A | pIC50 | 5.52 | 6.32 | 6.62 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pIC50 | 6.52 | 7.68 | 9.0 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pEC50 | 7.28 | 8.47 | 9.4 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pEC50 | 8.37 | 8.37 | 8.37 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pEC50 | 6.28 | 7.38 | 8.42 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pEC50 | 8.15 | 8.15 | 8.15 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pEC50 | 6.24 | 8.17 | 8.8 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pIC50 | 6.93 | 7.66 | 8.38 | ChEMBL |
D4 | DRD4 | Rat | Dopamine | A | pEC50 | 8.26 | 8.45 | 8.82 | ChEMBL |
D4 | DRD4 | Rat | Dopamine | A | pEC50 | 8.05 | 8.05 | 8.05 | Drug Central |